Marking International Women’s Day for a fourth year running, The Independent has compiled a list of the 50 most influential ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, recognizes ...
Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...
A Phase 1 clinical trial published in The Lancet has found that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treating myelomeningocele, a ...
Commercial launch is on-track for ZUSDURI, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results